Afferent Pharmaceuticals

Afferent Investors

Afferent Pharmaceuticals was launched in December 2009 and raised $23 million in Series A funding. Investors in Afferent include:

  investors Pappas Third Rock Ventures Domain Associates New Leaf Venture Partners